---









**MedXLink, Corp.**

NEVADA                                                        
11-2647209                                   
(State or other jurisdiction of                               
(IRS Employer
                                     
incorporation or organization)                              
Identification No.)



378 North Main, #124; Layton, UT 84041

Registrant's telephone number including area code						(801) 497-9075



Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section
13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter
period that the registrant was required to file such reports)

Yes X	No

and (2) has been subject to such filing requirements for the past 90 days.

Yes X	No



---



**ITEM 1 - FINANCIAL STATEMENTS**

The condensed financial statements included herein have been prepared by the Company,
pursuant to the rules and regulations of the Securities and Exchange Commission.

In the opinion of the Company, all adjustments, consisting of only normal recurring
adjustments, necessary to present fairly the financial position of the Company as of March 31, 2004
and the results of its operations and changes in its financial position from September 30, 2003
through March 31, 2004 have been made.  The results of its operations for such interim period is not
necessarily indicative of the results to be expected for the entire year.

---





(Unaudited)

|                                                                                                        | March 31,


2004 | September 30,


2003
|------------------------------------------------------------------------------------------------------- | ---------------- | --------------------
|**Assets**                                                                                             
|Current Assets                                                                                          |                  |                     
|Cash                                                                                                    | $	612            | $	803               
|Interest Receivable                                                                                     | -                | -                   
|Note Receivable                                                                                         | -                | -                   
|Total Assets                                                                                            | $	612            | $	803               
|                                                                                                        |                  |                     
|**Liabilities and Stockholders' Equity**                                                               
|Current Liabilities                                                                                     |                  |                     
|Accounts Payable                                                                                        | $	11,649         | $	8,292             
|Taxes Payable                                                                                           | 3,200            | 3,200               
|Interest Payable                                                                                        | 15,921           | 11,059              
|Notes Payable                                                                                           | 102,433          | 100,758             
|Total Current Liabilities                                                                               | 133,203          | 123,309             
|                                                                                                        |                  |                     
|Stockholders' Equity                                                                                    |                  |                     
|Common Stock; 100,000,000 Shares Authorized at $.001
Par Value; 2,487,794 Shares Issued and Outstanding | 2,488            | 2,488               
|Additional Paid in Capital                                                                              | 296,544          | 296,544             
|Retained Deficit                                                                                        | (431,623)        | (421,538)           
|                                                                                                        |                  |                     
|Total Stockholders' Equity (Deficit)                                                                    | (132,591)        | (122,506)           
|Total Liabilities and Stockholders' Equity                                                              | $	612            | $	803               

---



**MedXLink, Corp.**



|                                     | For the Three Months Ended | For the Six Months Ended
|------------------------------------ | -------------------------- | ------------------------
|                                     | March 31,


2004           | March 31,


2003        
|Revenue                              | $              -           | $              -        
|                                     |                            |                         
|Expenses                             |                            |                         
|General & Administrative             | 5,199                      | 3,690                   
|Total Expenses                       | 5,199                      | 3,690                   
|Loss from Operations                 | (5,199)                    | (3,690)                 
|                                     |                            |                         
|Other Income (Expenses)              |                            |                         
|Interest Income                      | -                          | -                       
|Interest Expense                     | (2,452)                    | (6,242)                 
|Total Other Income

(Expenses)       | (2,452)                    | (2,342)                 
|Net Income (Loss)

- Before Taxes    | (7,651)                    | (6,032)                 
|Taxes                                | -                          | -                       
|Net Income (Loss)                    | $    (7,651)               | $   (6,032)             
|                                     |                            |                         
|Loss per Common Share                | $              -           | $             -         
|Weighted Average

Outstanding Shares | 2,487,794                  | 2,256,594               

---



****





|                                                 | For the Six Months Ended
|------------------------------------------------ | ------------------------
|                                                 | March 31,


2004        
|Cash Flows from Operating Activities             |                         
|Net Income (Loss)                                | $    (10,085)           
|Adjustments to Reconcile Net (Loss) to Net Cash; |                         
|Increase in Interest Receivable                  | -                       
|Increase in Interest Payable                     | 4,862                   
|Increase in Taxes Payable                        | -                       
|Increase in Accounts Payable                     | 3,357                   
|Net Cash Provided (Used) by Operating Activities | (1,866)                 
|Cash Flows from Investing Activities             |                         
|(Increase) in Note Receivable                    | -                       
|Net Cash Provided (Used) by Investing Activities | -                       
|Cash Flows from Financing Activities             |                         
|Increase in Notes Payable                        | 1,675                   
|Net Cash Provided (Used) by Financing Activities | 1,675                   
|Increase (Decrease) in Cash                      | (191)                   
|Cash, Beginning of Period                        | 803                     
|Cash, End of Period                              | $          612          
|Supplemental Cash Flow Information               |                         
|Interest                                         | $              -        
|Income Taxes (Including Penalties & Interest)    | -                       

---







NOTE 1 - Interim Financial Statements

The financial statements for the six months ended March 31, 2004 were prepared from the books and
records of the company.  Management believes that all adjustments have been made to the financial
statements to make a fair presentation of the financial condition of the company as of March 31,
2004.  The results of the six months are not indicative of a full year of operation for the Company.

Certain information and footnote disclosures normally included in financial statements prepared in
accordance with generally accepted accounting principles, in the United States of America, have
been condensed or omitted.  It is suggested that these financial statements be read in conjunction
with the financial statements and notes thereto included in the Company's September 30, 2003
audited financial statements.  The results of operations for the periods ended March 31, 2004 are not
necessarily indicative of the operating results for the full year.

Liquidity and Capital Resources.  The Registrant had approximately $( 132,591) as operating
capital at March 31, 2004, compared to $(118,273) at March 31, 2003. The Registrant intends to
raise additional funds as needed through private placements with accredited and sophisticated
investors.

During the fourth fiscal quarter of 2002, the Company entered into an agreement to acquire
all of the equity of eHDL, Inc.  Closing of the acquisition would  not take place, if at all, until certain
events have occurred.  In anticipation of completing the acquisition, the Company sold $195,000 in
convertible debentures at an interest rate of 8% a.p.r. and due one year from date of issue to eHDL
investors.  The Company loaned all of the debenture proceeds to eHDL in an 8% a.p.r. promissory
note due on demand and eHDL has agreed to indemnify the Company from any financial
responsibility of the debentures.  It is unclear at this time whether the Company will have to repay
the debentures or honor a conversions due to the lack of eHDL's ability to perform on its guarantee.
In planning for its short term capital needs, the Company assumes that it will not have to repay the
debentures.  Should that change, the Company may have to seek bankruptcy protection.

Results of Operation.  Due to the lack of operations during the quarter ended March 31, 2004,
the registrant had a net loss of $(7,651) compared to a net loss of $(6,032) at March 31, 2003.

Plan of Operations.  The Company is currently in the process of looking for business
opportunities to acquire or merge with.  There is no guarantee that management will be successful
in finding such an opportunity.  During this process, the Company intends to raise operational capital
through private placements.

**ITEM 3 - CONTROLS AND PROCEDURES.**

(a) Evaluation of disclosure controls and procedures.  The Company's principal executive
officer and its principal financial officer, based on their evaluation of the Company's disclosure
controls over financial reporting and procedures (as defined in Exchange Act Rules 13a-14 (c)) as
of a date within 90 days prior to the filing of this Quarterly Report on Form 10-QSB, have concluded
that the Company's disclosure controls over financial reporting  and procedures are adequate and
effective for the purposes set forth in the definition in Exchange Act rules.

---

(b) Changes in internal controls over financial reporting.  There were no significant changes
in the Company's internal controls over financial reporting or in other factors that could significantly
affect the Company's internal controls subsequent to the date of their evaluation.



Item 1.	Legal Proceedings	None

Item 2.	Changes in Securities	None

Item 3.	Defaults Upon Senior Securities	None

Item 4.	Submission of Matters to a Vote of Security Holders	None

Item 5.	Other Information	None

Item 6.	Exhibits and Reports on Form 8-K

1) Exhibits.

31.  Written Statement of Chief Executive Officer and Chief Financial Officer with
respect to compliance with Section 302 of the Sarbanes-Oxley Act of 2002.

32.  Written Statement of Chief Executive Officer and Chief Financial Officer with
respect to compliance with Section 13(a) or 15(d) of  the Securities Exchange Act of
1934 and pursuant to 18 U.S.C. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002

2) Reports on Form 8-K.

a) Item 4, Change in Accountants, Filed February 17, 2004

---





Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned authorized officer.

Dated: May 14, 2004	**MedXLink, Corp.**



Dean Becker



---

**Exhibit 31**

**SECTION 302 CERTIFICATION**

I, Dean Becker, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of MedXLink, Corp;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this quarterly report.

3.  Based on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly
report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 12a-15(f) and 15d-15(f))  for the registrant and have:

a) Designed such disclosure controls and procedures or caused such controls and procedures to be
designed under my supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to me by others within those entities,
particularly during the period in which this quarterly report is being prepared.

b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and
presented in this report my conclusions about the effectiveness of the disclosure controls and
procedures as of the end of the period covered by this quarterly report based on such
evaluations; and

c) Disclosed in this report any change in the small business issuer's internal control over
financial reporting that occurred during the small business issuer's most recent fiscal quarter
that has materially affected, or is reasonably likely to materially affect, the registrant's
internal control over financial reporting.

5. I have disclosed, based on my most recent evaluation of internal control over financial
reporting,  to the registrant's auditors and the audit committee of registrant's board of directors (or
persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal
controls over financial reporting which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls over financial reporting; and

b) Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal controls over financial reporting.

Date: May 14, 2004

Dean Becker

Chief Executive Officer

And Principle Accounting Officer

---

**Exhibit 32**









(1) The Report fully complies with the requirements of section 13 (a) or 15 (d) of the
Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and result of operations of the Company.

Date: May 14, 2004

Dean Becker,

Chief Executive Officer

And Principle Accounting Officer

---